Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC: the phase 2 PACIFIC-6 trial
by Garassino, Marina (Author)
, Mazieres, Julien (Author)
, Reck, Martin (Author)
, Chouaid, Christos (Author)
, Bischoff, Helge (Author)
, Reinmuth, Niels (Author)
, Cove-Smith, Laura (Author)
, Mansy, Talal (Author)
, Cortinovis, Diego (Author)
, Migliorino, Maria R. (Author)
, Delmonte, Angelo (Author)
, Sánchez, José Garcia (Author)
, Chara Velarde, Luis Enrique (Author)
, Bernabe, Reyes (Author)
, Paz-Ares, Luis (Author)
, Perez, Ignacio Diaz (Author)
, Trunova, Nataliya (Author)
, Foroutanpour, Kayhan (Author)
, Faivre-Finn, Corinne (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource